A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy
一项针对接受抗血管生成治疗后病情进展的透明细胞肾细胞癌患者的西曲伐替尼联合纳武利尤单抗的1/2期临床试验
期刊:Science Translational Medicine
影响因子:14.6
doi:10.1126/scitranslmed.abm6420
Msaouel, Pavlos; Goswami, Sangeeta; Thall, Peter F; Wang, Xuemei; Yuan, Ying; Jonasch, Eric; Gao, Jianjun; Campbell, Matthew T; Shah, Amishi Yogesh; Corn, Paul Gettys; Tam, Alda L; Ahrar, Kamran; Rao, Priya; Sircar, Kanishka; Cohen, Lorenzo; Basu, Sreyashi; Duan, Fei; Jindal, Sonali; Zhang, Yuwei; Chen, Hong; Yadav, Shalini S; Shazer, Ronald; Der-Torossian, Hirak; Allison, James P; Sharma, Padmanee; Tannir, Nizar M
